Long-term outcomes after progestogen treatment for early endometrial cancer.

about

Comparison among fertility-sparing therapies for well differentiate early-stage endometrial carcinoma and complex atypical hyperplasia.Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review.

P2860

Q36376499-D98DE33B-759F-4AB2-8F33-7806AEE527CD Q42090449-D868C996-DF2D-4E87-A413-BB3CA4B82D0C

P2860

Long-term outcomes after progestogen treatment for early endometrial cancer.

Item

http://www.wikidata.org/entity/Q44627018

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Long-term outcomes after progestogen treatment for early endometrial cancer.

@en

Long-term outcomes after progestogen treatment for early endometrial cancer.

@nl

type

Item

label

Long-term outcomes after progestogen treatment for early endometrial cancer.

@en

Long-term outcomes after progestogen treatment for early endometrial cancer.

@nl

prefLabel

Long-term outcomes after progestogen treatment for early endometrial cancer.

@en

Long-term outcomes after progestogen treatment for early endometrial cancer.

@nl

P1476

Long-term outcomes after progestogen treatment for early endometrial cancer

@en

P2093

Deborah Neesham

http://www.w3.org/2001/XMLSchema#string

Robert M Rome

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors for young premenopausal women with endometrial cancer.

Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature.

Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review.

Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis.

Endometrial lesions in uteri resected for atypical endometrial hyperplasia.

Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma.

Progestogen treatment options for early endometrial cancer.

Characteristics and outcome of endometrial carcinoma patients age 45 years and younger.

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

P304

566-570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJO.12142

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael A. Quinn

Thomas J Cade

P577

2013-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24138444

http://www.w3.org/2001/XMLSchema#string

Long-term outcomes after progestogen treatment for early endometrial cancer.

about

P2860

P2860

Long-term outcomes after progestogen treatment for early endometrial cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698